United States
Germany
Japan
United Kingdom
China
CNY 10,260.00
3周
PIK3CA Mutant (Q546E), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | Q546E |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
CNY 10,260.00
3周
PIK3CA Mutant (I1062V), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | I1062V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (T1052K), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | T1052K |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (Y1021C), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | Y1021C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (H1065L), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | H1065L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (G1050D), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | G1050D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (G1049A), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | G1049A |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (E545D), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | E545D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (T1025S), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | T1025S |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (F1039L), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | F1039L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (C378R), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | C378R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (Q546H), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | Q546H |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (H1048Y), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | H1048Y |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (M1043T), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | M1043T |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 10,260.00
3周
PIK3CA Mutant (T1025N), Myc-DDK-tagged ORF clone of Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) as transfection-ready DNA
| Mutation | T1025N |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Lentivirus
Vectors
Conjugates
Isotypes
Clonalities
Families
Pathways
- Acute myeloid leukemia (98)
- Apoptosis (98)
- B cell receptor signaling pathway (98)
- Chemokine signaling pathway (98)
- Chronic myeloid leukemia (98)
- Colorectal cancer (98)
- Endometrial cancer (98)
- ErbB signaling pathway (98)
- Fc epsilon RI signaling pathway (98)
- Fc gamma R-mediated phagocytosis (98)
- Focal adhesion (98)
- Glioma (98)
- Inositol phosphate metabolism (98)
- Insulin signaling pathway (98)
- Jak-STAT signaling pathway (98)
- Leukocyte transendothelial migration (98)
- Melanoma (98)
- Natural killer cell mediated cytotoxicity (98)
- Neurotrophin signaling pathway (98)
- Non-small cell lung cancer (98)
- Pancreatic cancer (98)
- Pathways in cancer (98)
- Phosphatidylinositol signaling system (98)
- Progesterone-mediated oocyte maturation (98)
- Prostate cancer (98)
- Regulation of actin cytoskeleton (98)
- Renal cell carcinoma (98)
- Small cell lung cancer (98)
- T cell receptor signaling pathway (98)
- Toll-like receptor signaling pathway (98)
- Type II diabetes mellitus (98)
- VEGF signaling pathway (98)
- mTOR signaling pathway (98)
